Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Nat Med. 2022 Jan 20;28(3):486–489. doi: 10.1038/s41591-022-01704-7

Extended data Fig 1. 90% plaque reduction neutralization test (PRNT90) antibody titres to wild-type virus and Omicron BA.1 variant.

Extended data Fig 1.

PRNT90 antibody titres to Wild-type and Omicron Variant A. Individuals with 2 or 3 doses of BNT162b2 or CoronaVac vaccines, as indicated. B. SARS-CoV-2 convalescent individuals with or without BNT162b2 or CoronaVac vaccines (one dose). See table for numbers of individuals in each group. Mann-Whitney test (two tailed) was used for significance testing. P values are denoted. Dotted line indicates the threshold of protection and the shading indicates 95% confidence intervals (see text).